Search research articles

Related Concept Videos

Pleural Disorders: Types and Brief Description

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023

Same author

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850.

Oncotarget·2023

Same author

A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives.

Cells·2023

Same author

Clinical outcomes and immune phenotypes associated with <i>STK11</i> co-occurring mutations in non-small cell lung cancer.

Journal of thoracic disease·2022

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 25, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Pemetrexed for diffuse malignant pleural mesothelioma.

Christian Manegold¹, Joseph Aisner

¹Department of Medical Oncology/Internal Medicine, Thoraxklinik Heidelberg, gGmbH, Heidelberg, Germany.

Seminars in Oncology

|May 23, 2002

Summary

This summary is machine-generated.

Malignant pleural mesothelioma (MPM) treatment is challenging. New research shows pemetrexed plus cisplatin combination therapy offers a promising response rate for the epithelial subtype of this rare cancer.

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Related Experiment Videos

Last Updated: May 25, 2026

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Area of Science:

Oncology
Thoracic Surgery
Medical Research

Background:

Diffuse malignant pleural mesothelioma (MPM) presents significant treatment challenges.
Current therapies, including surgery, radiotherapy, and chemotherapy, offer limited survival benefits.
The epithelial subtype and complete surgical resection are associated with better prognoses.

Purpose of the Study:

To evaluate novel therapeutic agents for malignant pleural mesothelioma.
To investigate the efficacy of pemetrexed, a folate-based antimetabolite, in MPM treatment.
To assess the combination therapy of pemetrexed and cisplatin in MPM patients.

Main Methods:

Review of recent clinical trials and preliminary results for various chemotherapeutic agents.
Focus on pemetrexed, a thymidylate synthase inhibitor, and its mechanism of action.
Analysis of a Phase I study combining pemetrexed with cisplatin, noting response rates.

Main Results:

Pemetrexed and cisplatin combination therapy demonstrated a remarkable response rate of approximately 50% in patients with epithelial MPM.
Several agents like gemcitabine, raltitrexed, vinorelbine, and pemetrexed showed promising preliminary results.
A large international study was initiated to further evaluate the pemetrexed plus cisplatin combination.

Conclusions:

The combination of pemetrexed and cisplatin shows significant promise for treating malignant pleural mesothelioma, particularly the epithelial subtype.
Further investigation through large-scale clinical trials is warranted to establish this combination as a standard treatment.
Novel therapeutic strategies are crucial for improving outcomes in MPM patients.